Share

    


Home / Search Results

Search Results

You searched for:

Regardless of the reason, the ability to bill for discontinued services will depend on why the service had to be stopped and how it was addressed.
In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.